Monocarboxylate Transporter 6, Human (MCT6) (Control Peptide)
Catalog No : USB-M4470-50B
417.25€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Monocarboxylate Transporter 6, Human (MCT6) (Control Peptide) | ||
|---|---|---|---|
| Catalog No | USB-M4470-50B | ||
| Supplier’s Catalog No | M4470-50B | ||
| Supplier | US Biologicals | ||
| Source antigen | Human synthetic peptide | ||
| Reactivity | No significant sequence homology with other MCTs. MCT6 sequences from other species are not yet available. Control peptide, because of its low MW (<3kD), is not suitable for Western | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | Highly purified | ||
| Form | Supplied as a liquid in PBS, pH 7.2 | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Highly purified | ||
| Description | An 18-aa peptide sequence within the Cytoplasmic, C-terminus of human MCT6. Monocarboxylate such as lactate and pyruvate play an important role in cellular metabolism. Lactic acid is produced as the end product of glycolysis. Some tissues, such as white skeletal muscle and, red blood cells, use this pathway to generate most of their ATP under normal physiological conditions. All tissues become dependent on this pathway during abnormal conditions such as hypoxia and ischaemia. Lactic acid, produced during normal glycolysis, must be transported out of cells to sustain maintain high rate of glycolysis. Failure to export lactic acid leads to accumulation of cellular lactic acid followed by an increase in pH and inhibition of glycolysis. Some tissues, such as brain, heart, and red skeletal muscle, readily oxidize lactic acid, and must import lactic acid into the cells. Lactic acid transport is mediated by a group of proton-linked membrane transporters called monocarboxylic acid transporters (MCTs). At least 9 MCT-related proteins (MCT1-9) have been identified in mammals that are expressed in a tissue specific manner. MCT6/SLC16A5 (human 505-aa, ch 17q25.3) is highly expressed in kidney and placenta. According to new nomenclature, the old MCT5 has now been reclassified as MCT6. This antibody has previously been listed as MCT52-S. Please consult the main MCT page for details on the new nomenclature. | ||
Product Details
© 2020 Imugex All Rights Reserved